BioMatrix Specialty Pharmacy, a growing leader in the specialty pharmacy space, announced Tuesday the acquisition of City Drugs Specialty Pharmacy in New York City, NY. As a result of this transaction, BioMatrix broadens their reach in key therapeutic categories with new payer contracts adding additional covered lives and pharmacy staff extensively experienced in rare and chronic health conditions. The acquisition expands the organization’s national footprint to 12 pharmacy locations nationwide. City Drugs is located on the Upper East Side of Manhattan and specializes in the treatment of complex medical conditions including hepatitis, oncology, auto-immune diseases, and gastroenterology. City Drugs is accredited by URAC, The Joint Commission, and ACHC for Specialty Pharmacy with a Distinction in Oncology.
Read the full article: BioMatrix Expands National Footprint with Acquisition of City Drugs Specialty Pharmacy //
Source: https://www.prnewswire.com/news-releases/biomatrix-expands-national-footprint-with-acquisition-of-city-drugs-specialty-pharmacy-301069382.html
